Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

MA17.02 Early Accrual to a Precision Lung Cancer Survivorship Intervention: The Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program

Journal of Thoracic Oncology

English

P1.13-42 Activity of Novel HER2 Inhibitor, Poziotinib, for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance

Journal of Thoracic Oncology

English

PL02.07 IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC

Journal of Thoracic Oncology

English

P1.16-61 Intermittent Chest Tube Clamping Shortens Chest Tube Duration After Lung Cancer Surgery: An Interim Analysis of Randomized Clinical Trial

Journal of Thoracic Oncology

English

P1.01-64 Impact of STK11 Co-Mutation on Outcomes Following Immunotherapy Among Patients With TP53 and KRAS Mutated Stage IV NSCLC

Journal of Thoracic Oncology

English

P26 Respiratory Patient Preference and Satisfaction Rapidly Evaluated With Tablet PC Using the 18-Element Consultation Specific Questionnaire (CSQ): Comparison With Surgical Patients

English

P69 a Study of the Effect of the 2013 'Be Clear on Lung Cancer' Campaign on 2 Week Wait Referrals to an Inner North West London Cancer Centre

English

P3.07-08 Pain Management in Lung Cancer

Journal of Thoracic Oncology

English

P3.11-06 Improving Lung Cancer Screening Completion Rates in a Primary Care Practice in Large Urban Academic Medical Center

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

MA17.02 Early Accrual to a Precision Lung Cancer Survivorship Intervention: The Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program

P1.13-42 Activity of Novel HER2 Inhibitor, Poziotinib, for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance

PL02.07 IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC

P1.16-61 Intermittent Chest Tube Clamping Shortens Chest Tube Duration After Lung Cancer Surgery: An Interim Analysis of Randomized Clinical Trial

P1.01-64 Impact of STK11 Co-Mutation on Outcomes Following Immunotherapy Among Patients With TP53 and KRAS Mutated Stage IV NSCLC

P26 Respiratory Patient Preference and Satisfaction Rapidly Evaluated With Tablet PC Using the 18-Element Consultation Specific Questionnaire (CSQ): Comparison With Surgical Patients

P69 a Study of the Effect of the 2013 'Be Clear on Lung Cancer' Campaign on 2 Week Wait Referrals to an Inner North West London Cancer Centre

P3.07-08 Pain Management in Lung Cancer

P3.11-06 Improving Lung Cancer Screening Completion Rates in a Primary Care Practice in Large Urban Academic Medical Center